BRIEF published on 04/09/2025 at 07:05, 1 year 5 months ago Vaccination du premier enfant dans l'étude de Phase 2 sur le vaccin S4V2 contre la shigellose Valneva Phase 2 Shigellose Vaccin S4V2 Essai Pédiatrique
BRIEF published on 04/09/2025 at 07:05, 1 year 5 months ago First child vaccinated in Phase 2 study of S4V2 shigellosis vaccine Valneva Phase 2 Shigellosis S4V2 Vaccine Pediatric Trial
BRIEF published on 04/09/2025 at 06:45, 1 year 5 months ago Bondholder Meetings Approve Amendments by Meyer Burger Convertible Bonds Bondholder Approval Meyer Burger Financial Strategy 2027 And 2029 Amendments
BRIEF published on 04/09/2025 at 06:45, 1 year 5 months ago Les assemblées des porteurs d'obligations approuvent les amendements de Meyer Burger Obligations Convertibles Stratégie Financière Meyer Burger Approbation Des Détenteurs D'obligations Amendements De 2027 Et 2029
BRIEF published on 04/09/2025 at 06:35, 1 year 5 months ago Cham Swiss Properties Makes Market Debut After Successful Merger Shareholder Approval SIX Swiss Exchange Real Estate Portfolio Merger Completion Cham Swiss Properties
BRIEF published on 04/09/2025 at 06:35, 1 year 5 months ago Cham Swiss Properties fait ses débuts sur le marché après une fusion réussie Portefeuille Immobilier SIX Swiss Exchange Approbation Des Actionnaires Finalisation De La Fusion Cham Swiss Properties
BRIEF published on 04/09/2025 at 04:05, 1 year 5 months ago QNX Enhances WeRide's ADAS Platform for Chery's Models Autonomous Driving ADAS QNX WeRide Chery Models
BRIEF published on 04/09/2025 at 04:05, 1 year 5 months ago QNX améliore la plateforme ADAS de WeRide pour les modèles Chery ADAS Conduite Autonome QNX Nousroulons Modèles Chery
BRIEF published on 04/08/2025 at 23:50, 1 year 5 months ago Redcare Pharmacy Issues New Convertible Bonds and Buys Back Existing Ones Convertible Bonds Shareholder Dilution Debt Management Financial Strategy E-Pharmacy
BRIEF published on 04/08/2025 at 23:50, 1 year 5 months ago Redcare Pharmacy émet de nouvelles obligations convertibles et rachète les obligations existantes Obligations Convertibles Stratégie Financière Gestion De La Dette Dilution Des Actionnaires Pharmacie En Ligne
Published on 09/12/2026 at 02:35, 16 hours 28 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 20 hours 3 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 20 hours 58 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 21 hours 38 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 2 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 hour 13 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 11 hours 33 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 20 hours 48 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 20 hours 53 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 23 hours 18 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 12 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 12 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 23 hours ago Availability of the 2026 Interim Financial Report
